| Literature DB >> 24672688 |
Antonis Papaiwannou1, Paul Zarogoulidis1, Konstantinos Porpodis1, Dionysios Spyratos1, Ioannis Kioumis1, Georgia Pitsiou1, Athanasia Pataka1, Kosmas Tsakiridis1, Stamatis Arikas1, Andreas Mpakas1, Theodora Tsiouda1, Nikolaos Katsikogiannis1, Ioanna Kougioumtzi1, Nikolaos Machairiotis1, Stavros Siminelakis1, Alexander Kolettas1, George Kessis1, Thomas Beleveslis1, Konstantinos Zarogoulidis1.
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are chronic diseases, very common in general population. These obstructive airway illnesses are manifested with chronic inflammation affecting the whole respiratory tract. Obstruction is usually intermittent and reversible in asthma, but is progressive and irreversible in COPD. Asthma and COPD may overlap and converge, especially in older people [overlap syndrome-asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS)]. Although ACOS accounts approximately 15-25% of the obstructive airway diseases, is not well recognised because of the structure of clinical trials. COPD studies exclude asthma patients and asthma studies exclude COPD patients, respectively. It is crucial to define asthma, COPD and overlap syndrome (ACOS), as notable clinical entities, which they share common pathologic and functional features, but they are characterized from differences in lung function, acute exacerbations, quality of life, hospital impact and mortality.Entities:
Keywords: Chronic obstructive pulmonary disease (COPD); asthma; overlap
Year: 2014 PMID: 24672688 PMCID: PMC3966158 DOI: 10.3978/j.issn.2072-1439.2014.03.04
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895